+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition

Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition

Antimicrobial Agents and Chemotherapy 44(4): 958-966

We previously demonstrated that pentamidine, which has been clinically used against Pneumocystis carinii, inhibits in vitro a group I intron ribozyme from that organism. Another fungal pathogen, Candida albicans, also harbors a group I intron ribozyme (Ca.LSU) in the essential rRNA genes in almost half of the clinical isolates analyzed. To determine whether pentamidine inhibits Ca.LSU in vitro and in cells, phylogenetically closely related intron-containing (4-1) and intronless (62-1) strains were studied. Splicing in vitro of the Ca.LSU group I intron ribozyme was completely inhibited by pentamidine at 200 microM. On rich glucose medium, the intron-containing strain was more sensitive to growth inhibition by pentamidine than was the intronless strain, as measured by disk or broth microdilution assays. On rich glycerol medium, they were equally susceptible to pentamidine. At pentamidine levels selectively inhibiting the intron-containing strain (1 microM) in glucose liquid cultures, inhibition of splicing and rRNA maturation was detected by quantitative reverse transcription-PCR within 1 min with a 10- to 15-fold accumulation of precursor rRNA. No comparable effect was seen in the intronless strain. These results correlate the cellular splicing inhibition of Ca.LSU with the growth inhibition of strain 4-1 harboring Ca.LSU. Broth microdilution assays of 13 Candida strains showed that intron-containing strains were generally more susceptible to pentamidine than the intronless strains. Our data suggest that ribozymes found in pathogenic microorganisms but absent in mammals may be targets for antimicrobial therapy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 003520772

Download citation: RISBibTeXText

PMID: 10722497

DOI: 10.1128/aac.44.4.958-966.2000

Related references

Group I intron as therapeutic target A preliminary study on the growth inhibition of Candida albicans by bleomycin. Journal of Biomolecular Structure & Dynamics 20(6): 871, 2003

Binding enhancement by tertiary interactions and suicide inhibition of a Candida albicans group I intron by phosphoramidate and 2'-O-methyl hexanucleotides. Biochemistry 40(21): 6520-6526, 2001

Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing. Proceedings of the National Academy of Sciences of the United States of America 99(17): 11091-6, 2002

Tetrahymena thermophila and Candida albicans group I intron-derived ribozymes can catalyze the trans-excision-splicing reaction. Nucleic Acids Research 36(16): 5281-5289, 2008

A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene (amsterdam). 180(1-2): 189-196, 1996

Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. Journal of Molecular Biology 226(4): 935-941, 1992

Inhibition of in vitro splicing of a group I intron of Pneumocystis carinii. Journal of Eukaryotic Microbiology 41(1): 31-38, 1994

New approaches to targeting RNA with oligonucleotides: inhibition of group I intron self-splicing. Biopolymers 73(1): 151-161, 2004

Inhibition of self-splicing group I intron RNA: high-throughput screening assays. Nucleic Acids Research 24(24): 5051-5053, 1996

Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine. Journal of Medical and Veterinary Mycology 26(2): 119-126, 1988

Specific inhibition of Candida albicans growth in vitro by antibodies from experimental Candida keratitis mice. Experimental Eye Research 93(1): 50-58, 2011

In vitro suicide inhibition of self-splicing of a group I intron from Pneumocystis carinii by an N3' fwdarw P5' phosphoramidate hexanucleotide. Proceedings of the National Academy of Sciences of the United States of America 96(6): 2734-2739, 1999

Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. Journal of Clinical Microbiology 39(12): 4309-4315, 2001

Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro. International Journal of Antimicrobial Agents 36(4): 380-382, 2010

The effect of surface roughness of silicone-based resilient liner materials on the adherence of Candida albicans and inhibition of Candida albicans with different disinfectants. Oral Health and Preventive Dentistry 7(4): 347-353, 2009